Comparative Risk of Serious Infections With Tumor Necrosis Factor α Antagonists vs Vedolizumab in Patients With Inflammatory Bowel Diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparative Risk of Serious Infections With Tumor Necrosis Factor α Antagonists vs Vedolizumab in Patients With Inflammatory Bowel Diseases

Published:2022-02 Issue:2 Volume:20 Page:e74-e88
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Singh Siddharth^ORCID,Heien Herbert C.,Herrin Jeph,Dulai Parambir S.,Sangaralingham Lindsey,Shah Nilay D.,Sandborn William J.

Funder

AbbVie

National Institutes of Health

Takeda Pharmaceutical Company

National Institute of Diabetes and Digestive and Kidney Diseases

Prometheus

Pfizer

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference27 articles.

1. Vedolizumab versus adalimumab for moderate-to-severe ulcerative colitis;Sands;N Engl J Med,2019

2. Comparison of infliximab and adalimumab in biologic-naive patients with ulcerative colitis: a nationwide Danish cohort study;Singh;Clin Gastroenterol Hepatol,2017

3. Comparison of infliximab with adalimumab in 827 biologic-naive patients with Crohn's disease: a population-based Danish cohort study;Singh;Aliment Pharmacol Ther,2018

4. Comparative effectiveness and safety of anti–tumor necrosis factor agents in biologic-naive patients with Crohn's disease;Singh;Clin Gastroenterol Hepatol,2016

5. First- and second-line pharmacotherapies for patients with moderate to severely active ulcerative colitis: an updated network meta-analysis;Singh;Clin Gastroenterol Hepatol,2020

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Safety and Effectiveness of Ustekinumab and Anti-TNF in Elderly Crohn’s Disease Patients;Inflammatory Bowel Diseases;2024-08-03

2. Comparative Risk of Serious Infection With Vedolizumab vs Anti-Tumor Necrosis Factor in Inflammatory Bowel Disease: Results From Nationwide Swedish Registers;American Journal of Gastroenterology;2024-07-12

3. Association between vedolizumab and risk of clostridium difficile infection in patients with ulcerative colitis: A systematic review and meta-analysis;Saudi Journal of Gastroenterology;2024-06-07

4. Impact of Treatment Response on Risk of Serious Infections in Patients With Crohn’s Disease: Secondary Analysis of the PYRAMID Registry;Clinical Gastroenterology and Hepatology;2024-06

5. Precision medicine in inflammatory bowel diseases;Intestinal Research;2024-01-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3